Psychiatry Research
Volume 135, Issue 3 , Pages 185-190 , 30 June 2005

Plasma concentrations of anxiolytic neuroactive steroids in men with panic disorder

  • Francesca Brambilla

      Affiliations

    • Department of Psychiatry, Sacco Hospital, Milan, Italy
    • Corresponding Author InformationCorresponding author. Centro di Psiconeuroendocrinologia, Piazza Grandi 3, Milano 20129, Italy. Tel.: +39 2 717350; fax: +39 2 70122889.
    • ,
  • Carmen Mellado

      Affiliations

    • Department of Psychiatry, Sacco Hospital, Milan, Italy
    • ,
  • Alessandra Alciati

      Affiliations

    • Department of Psychiatry, Sacco Hospital, Milan, Italy
    • ,
  • Maria Giuseppina Pisu

      Affiliations

    • Department of Experimental Biology, Center of Excellence for Neurobiology of Dependence, and C.N.R., Institute of Neuroscience, Unit of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy
    • ,
  • Robert H. Purdy

      Affiliations

    • Department of Psychiatry, Veterans Affairs Medical Center, University of California, San Diego, CA, USA
    • ,
  • Stefano Zanone

      Affiliations

    • Department of Psychiatry, Padua University, Padua, Italy
    • ,
  • Giulia Perini

      Affiliations

    • Department of Psychiatry, Padua University, Padua, Italy
    • ,
  • Mariarosa Serra

      Affiliations

    • Department of Experimental Biology, Center of Excellence for Neurobiology of Dependence, and C.N.R., Institute of Neuroscience, Unit of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy
    • ,
  • Giovanni Biggio

      Affiliations

    • Department of Experimental Biology, Center of Excellence for Neurobiology of Dependence, and C.N.R., Institute of Neuroscience, Unit of Neuropsychopharmacology, University of Cagliari, Cagliari, Italy

Received 25 June 2004 ,Revised 14 November 2004 ,Accepted 16 November 2004.

References 

  1. American Psychiatric Association . Diagnostic and Statistical Manual of Mental Disorders. 4th edition. Washington, DC: APA; 1994;
  2. Argyle N, Deltito J, Allerup P, Albus M, Nutziger D, Rasmussen S, et al. The Panic-Associated Symptoms Scale: measuring the severity of panic disorder. Acta Psychiatrica Scandinavica. 1991;83:20–31
  3. Barbaccia ML, Lello S, Sidiropoulou T, Cocco T, Sorge SP, Cocchiarale A, et al. Plasma 5α-androstane-3α-17β-diol, an endogenous steroid that positively modulates GABA receptor function and anxiety: a study in menopausal women. Psychoneuroendocrinology. 2000;25:659–675
  4. In:  Biggio G,  Purdy RH editor. Neurosteroids and Brain Function. International Review of Neurobiology. vol. 46:San Diego: Academic Press; 2001;
  5. Brambilla F, Biggio G, Pisu MG, Bellodi L, Perna G, Bogdanovich-Djukic V, et al. Neurosteroid secretion in panic disorder. Psychiatry Research. 2003;118:107–116
  6. Brambilla F, Biggio G, Pisu MG, Purdy RH, Gerra G, Zaimovich A, et al. Plasma concentrations of anxiolytic neurosteroids in men with normal anxiety scores: a correlation analysis. Neuropsychobiology. 2004;50:6–9
  7. Heydary B, Le Mélledo JW. Low pregnenolone sulphate plasma concentrations in patients with generalized social phobia. Psychological Medicine. 2002;32:929–933
  8. Gee KW, Bolger MB, Brinton RE, Coirini H, McEwen B. Steroid modulation of the chloride ionophore in rat brain: structure-activity requirements, regional dependence and mechanism of action. Journal of Pharmacology and Experimental Therapeutics. 1988;246:803–812
  9. Klein DF, Skrobala A, Garfinkel RS. A preliminary look at the effects of pregnancy on the course of panic disorder. Anxiety. 1995;1:227–232
  10. Lambert J, Belelli D, Hill , Venning C, Peters JA. Neurosteroids and GABAA receptor function. Trends in Pharmacological Sciences. 1995;16:295–303
  11. Le Mélledo JM, Merani S, Koszychi D, Bellavance F, Palmour R, Gutkowska J, et al. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases. Neuropsychopharmacology. 1999;20:81–91
  12. Majewska MD, Demirgoren S, Spivak CE, London ED. The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABAA receptor. Brain Research. 1979;526:143–146
  13. Marks IM, Mathews AM. Brief standard self-rating for phobic patients. Behavioral Research and Therapy. 1979;17:263–267
  14. Paul SM, Purdy RH. Neuroactive steroids. FASEB Journal. 1992;6:2311–2322
  15. Perna G, Brambilla F, Arancio C, Bellodi L. Menstrual cycle-related sensitivity to 35% CO2 in panic patients. Biological Psychiatry. 1995;37:528–532
  16. Purdy RH, Morrow AL, Blinn JR, Paul SM. Synthesis, metabolism and pharmacological activity of 3α-hydroxysteroids which potentiate GABA-receptor-mediated chloride ion uptake in rat cerebral cortical synaptoneurosomes. Journal of Medical Chemistry. 1991;33:1572–1581
  17. Purdy RH, Morrow AL, Moore PH, Paul SM. Stress-active steroids induced elevation of γ-amino-butyric acid receptor which in rat potentiates GABA-receptor-mediated chloride ion uptake cerebral cortical synaptoneurosomes. Proceedings of the National Academy of Sciences of the United States of America. 1991;88:4553–4557
  18. Semeniuk L, Jhanddri G, Le Mélledo JM. Neuroactive steroid plasma levels in patients with generalized anxiety disorder. Journal of Neuropsychiatry and Clinical Neurosciences. 2001;13:396–398
  19. Serra M, Madau MF, Chessa M, Caddeo M, Senna E, Trapani G, et al. 2-Phenyl-imidazol-[1,2-a]-pyridine derivatives as ligands for peripheral benzodiazepine receptors: stimulation of neurosteroid synthesis and anticonflict action. British Journal of Pharmacology. 1999;127:177–182
  20. Sheehan, D.V., Lecrubier, Y., Janavs, J., Knapp, E., Weiler, E., Bonora, P., Sheedan, M., Amorim, P., Baker, R., Sheehan, K. H., Lepine, J.P., 1994. MINI International Neuropsychiatric Interview. Paris-Tampa.
  21. In:  Smith SS editors. Neurosteroid Effects in the Central Nervous System: The Role of the GABAA Receptor. Methods and New Frontiers in Neuroscience. Boca Raton, FL: CRC Press; 2003;
  22. Spielberger CD, Gorsuch R, Lushere R. STAI. Manual for the State-Trait Anxiety Inventory. Palo Alto, CA: Consulting Psychologists Press; 1970;
  23. Spivak B, Maayin R, Kotler M, Mester R, Gil-Ad I, Shtauf FB. Elevated circulatory levels of GABA antagonistic neurosteroids in patients with combat-related posttraumatic stress disorder. Psychological Medicine. 2000;30:1227–1231
  24. Ströhle A, Romeo E, Di Michele F, Pasini A, Spalletta G, Di Michele F, et al. GABAA receptor-modulating neuroactive steroid composition in patients with panic disorder before and during paroxetine treatment. American Journal of Psychiatry. 2002;159:145–148
  25. Ströhle A, Romeo E, Di Michele F, Pasini A, Hermann B, Gajewsky G, et al. Induced panic attacks shift gamma-aminobutyric acid type A receptor modulatory neuroactive steroid composition in patients with panic disorder. Archives of General Psychiatry. 2003;60:161–168
  26. Tait GR, McManus K, Bellavance F, Lara N, Chrapo W, Le Mèlledo JM. Neuroactive steroid changes in response to challenge with the panicogenic agent pentagastrin. Psychoneuroendocrinology. 2002;27:417–429

PII: S0165-1781(05)00136-8

doi: 10.1016/j.psychres.2004.11.009

Psychiatry Research
Volume 135, Issue 3 , Pages 185-190 , 30 June 2005

Article Tools

* Image Usage & Resolution